Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324350 · ClinicalTrials.gov registry record · Phase 3
Intensive Glycemic Control and Skeletal Health Study
A Phase 3 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 7,287
- Enrollment target
NCT00324350 is a Phase 3 study that has completed, run by University of California, San Francisco. The registered enrollment target is 7,287 participants.
The verdict
NCT00324350, a Phase 3 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 7,287 participants
- Enrollment target
Study Summary
The purpose of the ACCORD-BONE Study is to investigate the effects of intensive glycemic control for type 2 diabetes (in ACCORD participants) on factors related to bone health, including, fractures, falls, and bone mineral density.
Interventions
- DRUG hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,287 participants |
| Start Date | 2003-10 |
| Est. Completion | 2009-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00324350
The ClinicalTrials.gov registry entry for NCT00324350 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 7,287 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents is the first listed.
NCT00324350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00324350 about?
NCT00324350 is a clinical study titled "Intensive Glycemic Control and Skeletal Health Study". The purpose of the ACCORD-BONE Study is to investigate the effects of intensive glycemic control for type 2 diabetes (in ACCORD participants) on factors related to bone health, including, fractures, falls, and bone mineral density.
What is the current status of trial NCT00324350?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 7,287 participants. The study started on 2003-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00324350?
The interventions under investigation include: hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents (DRUG).
Who is sponsoring clinical trial NCT00324350?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.